dihexa treatment for dementia Peptide Therapy | Memory & Cognition dihexa dementia Vascular Dementia |

The Phase 2 Trial: NCT07437547 In February 2026, Hudson Biotech began recruiting participants for the first properly designed randomized controlled trial of BPC-157 in humans

Some studies also point to its role in supporting brain-derived neurotrophic factor, a protein that helps neurons survive and form new connections

But some symptoms include: Flashbacks formation and intrusive memories

Additionally, personalized treatment often involves monitoring and adjustments

If you're a tested athlete, you should also be aware that anti-doping rules can apply: USADA notes BPC-157 is prohibited under WADA's Prohibited List as an "unapproved substance"